SpyBiotech
PrivateLast Round
Grant
Mar 20, 2023
Est. Valuation
$9.73M
Total Funding Raised
$71.5M
Company Overview
SpyBiotech is a biotechnology company that develops vaccines against infectious diseases and cancer using its proprietary protein superglue technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpyBiotech Comparables
Compare SpyBiotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nCage Therapeutics | 79% | |
| Mevox | 76% | |
| AstraZeneca | 71% | |
SpyBiotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 20, 2023 | ||||
| Grant | Nov 1, 2022 | ||||
| Series A | Feb 10, 2021 | ||||
| Convertible Debt | Sep 1, 2020 | ||||
| Seed | Mar 31, 2017 |
Key People
Founding team and executive leadership
SpyBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Series A |
| GV | Seed, Series A |
| Oxford Science Enterprises | Convertible Debt, Series A, Seed |
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Oxford Investment Consultants | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2025
Stuart Chaffee joins as an independent member of the Board of Directors.
- Feb 10, 2021
$33M round led by Braavos Investment Advisers.
SpyBiotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SpyBiotech's valuation, stock price, and market status.